Base de dados : LILACS
Pesquisa : D08.811.277.352.365.300 [Categoria DeCS]
Referências encontradas : 1 [refinar]
Mostrando: 1 .. 1   no formato [Detalhado]

página 1 de 1

  1 / 1 LILACS  
             
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: lil-742974
Autor: Abrão, Wanderci Marys Oliveira; Mello, Luane Marques de; Silva, Anderson Soares da; Nunes, Altacílio Aparecido.
Título: Impact of the antipneumococcal conjugate vaccine on the occurrence of infectious respiratory diseases and hospitalization rates in children
Fonte: Rev. Soc. Bras. Med. Trop;48(1):44-49, jan-feb/2015. tab.
Idioma: en.
Resumo: INTRODUCTION: In 2010, to reduce the occurrence of serious pneumococcal disease, the Ministry of Health in Brazil incorporated the 10-valent pneumococcal vaccine in the immunization schedule of children younger than two years of age. The objective of this study was to evaluate the impact of vaccination on the incidence of infectious respiratory diseases in infants before and after the introduction of the 10-valent pneumococcal vaccine. METHODS: This cross-sectional study involved primary care and hospital networks from a city in Minas Gerais State, Brazil, between 2009 and 2012. RESULTS: A 40% reduction in the prevalence of community-acquired pneumonia (CAP) was observed after introducing the pneumococcal conjugate vaccine. Male children were 28% more likely to develop the disease. The prevalence ratio ([PR] = 1.96, 95% CI: 1.52 to 2.53, p < 0.05) suggested that not being vaccinated was associated with the occurrence of pneumonia. The prevalence of CAP was 70% lower (PR 0.30, 95% CI: 0.24 to 0.37, p<0.05) in children vaccinated as recommended compared to children with delayed vaccination, suggesting that the updated vaccine schedule improves protection. CONCLUSIONS: Immunization with the 10-valent pneumococcal vaccine appeared to reduce the number of pneumonia cases in children during the study period. Prospective studies are needed to confirm the efficacy of the vaccine against the occurrence of pneumococcal pneumonia. .
Descritores: HIV-1
RNA Mensageiro/metabolismo
RNA Viral/metabolismo
Proteínas de Ligação a RNA/metabolismo
-Processamento Alternativo
Western Blotting
Endorribonucleases/genética
Endorribonucleases/metabolismo
Exorribonucleases/genética
Exorribonucleases/metabolismo
HEKABORTION, INCOMPLETEABATTOIRS CELLS
HIV-1
Interações Hospedeiro-Patógeno
Imunoprecipitação
Ligação Proteica
Interferência de RNA
RNA Mensageiro/genética
RNA Viral/genética
Proteínas de Ligação a RNA/genética
Transativadores/genética
Transativadores/metabolismo
Limites: Seres Humanos
Tipo de Publ: Research Support, Non-U.S. Gov't
Responsável: BR1.1 - BIREME



página 1 de 1
   


Refinar a pesquisa
  Base de dados : Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde